[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Latin America, Middle East & Africa Cardiac Biomarkers Testing Market (2019-2025)

June 2019 | 103 pages | ID: LD85D6BC277EN
KBV Research

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The Latin America, Middle East and Africa Cardiac Biomarkers Testing Market would witness market growth of 12.4% CAGR during the forecast period (2019–2025).

Conventional laboratory tests use cardiac biomarkers to examine the cardiac anomalies that result in cardiac arrest and ACS. Since these laboratories focus on providing reliable and accurate results, the vendors are increasingly concentrating on developing cardiac biomarkers for laboratory services. Hospitals make use of cardiac biomarkers to rapidly detect myocardial necrosis and to increase the survival rate of patients. Hospitals and specialty clinics use cardiac biomarkers for imaging procedures for cardiology to detect the level of anomalies which may lead to heart failure. Specialty clinics offer specialized health packages at reduced costs for imaging services for patients suffering from diabetes accompanied by cardiac abnormalities.

Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.

Scope of the Study

Market Segmentation:

By Type
  • Creatine Kinase (CK-MB)
  • Troponins
  • Myoglobin
  • Natriuretic Peptides (BNP and NT-proBNP)
  • Ischemia Modified Albumin
  • Others
By Application
  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others
By Location of Testing
  • Point of Care Testing
  • Laboratory Testing
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Trivitron Healthcare Pvt. Ltd.
  • Abbott Laboratories
  • Siemens AG
  • Becton, Dickinson AND Company
  • Bio-Rad Laboratories, Inc.
  • Randox Laboratories Limited
  • Danaher Corporation
      • Thermo Fisher Scientific, Inc.
  • Johnson and Johnson
  • Quidel Corporation
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 LAMEA Cardiac Biomarkers Testing Market, by Type
  1.4.2 LAMEA Cardiac Biomarkers Testing Market, by Application
  1.4.3 LAMEA Cardiac Biomarkers Testing Market, by Location of Testing
  1.4.4 LAMEA Cardiac Biomarkers Testing Market, by Geography
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
  2.1.2 Executive Summary
  2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraint

CHAPTER 3. LAMEA CARDIAC BIOMARKERS TESTING MARKET BY TYPE

  3.1.1 LAMEA Creatine Kinase (CK-MB) Market by Country
  3.1.2 LAMEA Troponins Market by Country
  3.1.3 LAMEA Myoglobin Market by Country
  3.1.4 LAMEA Natriuretic Peptides (BNP and NT-proBNP) Market by Country
  3.1.5 LAMEA Ischemia Modified Albumin Market by Country
  3.1.6 LAMEA Others Market by Country

CHAPTER 4. LAMEA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION

  4.1.1 LAMEA Myocardial Infarction Market by Country
  4.1.2 LAMEA Congestive Heart Failure Market by Country
  4.1.3 LAMEA Acute Coronary Syndrome Market by Country
  4.1.4 LAMEA Atherosclerosis Market by Country
  4.1.5 LAMEA Others Market by Country

CHAPTER 5. LAMEA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING

  5.1.1 LAMEA Point of Care Testing Market by Country
  5.1.2 LAMEA Laboratory Testing Market by Country

CHAPTER 6. LAMEA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY

6.1 Brazil Cardiac Biomarkers Testing Market
  6.1.1 Brazil Cardiac Biomarkers Testing Market by Type
  6.1.2 Brazil Cardiac Biomarkers Testing Market by Application
  6.1.3 Brazil Cardiac Biomarkers Testing Market by Location of Testing
6.2 Argentina Cardiac Biomarkers Testing Market
  6.2.1 Argentina Cardiac Biomarkers Testing Market by Type
  6.2.2 Argentina Cardiac Biomarkers Testing Market by Application
  6.2.3 Argentina Cardiac Biomarkers Testing Market by Location of Testing
6.3 UAE Cardiac Biomarkers Testing Market
  6.3.1 UAE Cardiac Biomarkers Testing Market by Type
  6.3.2 UAE Cardiac Biomarkers Testing Market by Application
  6.3.3 UAE Cardiac Biomarkers Testing Market by Location of Testing
6.4 Saudi Arabia Cardiac Biomarkers Testing Market
  6.4.1 Saudi Arabia Cardiac Biomarkers Testing Market by Type
  6.4.2 Saudi Arabia Cardiac Biomarkers Testing Market by Application
  6.4.3 Saudi Arabia Cardiac Biomarkers Testing Market by Location of Testing
6.5 South Africa Cardiac Biomarkers Testing Market
  6.5.1 South Africa Cardiac Biomarkers Testing Market by Type
  6.5.2 South Africa Cardiac Biomarkers Testing Market by Application
  6.5.3 South Africa Cardiac Biomarkers Testing Market by Location of Testing
6.6 Nigeria Cardiac Biomarkers Testing Market
  6.6.1 Nigeria Cardiac Biomarkers Testing Market by Type
  6.6.2 Nigeria Cardiac Biomarkers Testing Market by Application
  6.6.3 Nigeria Cardiac Biomarkers Testing Market by Location of Testing
6.7 Rest of LAMEA Cardiac Biomarkers Testing Market
  6.7.1 Rest of LAMEA Cardiac Biomarkers Testing Market by Type
  6.7.2 Rest of LAMEA Cardiac Biomarkers Testing Market by Application
  6.7.3 Rest of LAMEA Cardiac Biomarkers Testing Market by Location of Testing

CHAPTER 7. COMPANY PROFILES

7.1 Trivitron Healthcare Pvt. Ltd.
  7.1.1 Company Overview
  7.1.2 Recent strategies and developments:
    7.1.2.1 Collaborations, partnerships and agreements:
    7.1.2.2 Expansion:
7.2 ABBOTT Laboratories
  7.2.1 Company Overview
  7.2.2 Financial Analysis
  7.2.3 Segmental and Regional Analysis
  7.2.4 Research & Development Expense
  7.2.1 Recent strategies and developments:
    7.2.1.1 Acquisition and mergers:
    7.2.1.2 Product launches:
    7.2.1.3 Approvals:
  7.2.2 SWOT Analysis
7.3 Siemens AG (Siemens Healthineers, Inc.)
  7.3.1 Company Overview
  7.3.2 Financial Analysis
  7.3.3 Segmental and Regional Analysis
  7.3.4 Research & Development Expense
  7.3.5 Recent strategies and developments:
    7.3.5.1 Collaborations, partnerships and agreements:
    7.3.5.2 Product launches:
  7.3.6 SWOT Analysis
7.4 Becton, Dickinson and Company
  7.4.1 Company Overview
  7.4.2 Financial Analysis
  7.4.3 Segmental and Regional Analysis
  7.4.4 Research & Development Expense
  7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
  7.5.1 Company Overview
  7.5.2 Financial Analysis
  7.5.3 Segmental and Regional Analysis
  7.5.4 Research & Development Expenses
  7.5.5 Recent strategies and developments:
    7.5.5.1 Acquisition and mergers:
7.6 Randox Laboratories Limited
  7.6.1 Company Overview
  7.6.2 Recent strategies and developments:
    7.6.2.1 Collaborations, partnerships and agreements:
7.7 Danaher Corporation (Beckman Coulter, Inc.)
  7.7.1 Company Overview
  7.7.2 Financial Analysis
  7.7.3 Segmental and Regional Analysis
  7.7.4 Research & Development Expense
  7.7.5 Recent strategies and developments:
    7.7.5.1 Collaborations, partnerships and agreements:
    7.7.5.2 Approvals:
  7.7.6 SWOT Analysis
7.8 Thermo Fischer Scientific, Inc.
  7.8.1 Company Overview
  7.8.2 Financial Analysis
  7.8.3 Segmental and Regional Analysis
  7.8.4 Research & Development Expense
  7.8.5 Recent strategies and developments:
    7.8.5.1 Acquisition and mergers:
  7.8.6 SWOT Analysis
7.9 Johnson and Johnson
  7.9.1 Company Overview
  7.9.2 Financial Analysis
  7.9.3 Segmental &Regional Analysis
  7.9.4 Research & Development Expenses
  7.9.5 Recent strategies and developments:
    7.9.5.1 Collaborations, partnerships and agreements:
    7.9.5.2 Acquisition and mergers:
  7.9.6 SWOT Analysis
7.1 Quidel Corporation
  7.10.1 Company Overview
  7.10.2 Financial Analysis
  7.10.3 Regional Analysis
  7.10.4 Research & Development Expenses

LIST OF TABLES

TABLE 1 LAMEA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 2 LAMEA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 3 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 LAMEA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 LAMEA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 LAMEA TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 LAMEA TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 LAMEA MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 LAMEA MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 LAMEA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 LAMEA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 LAMEA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 LAMEA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 LAMEA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 LAMEA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 18 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 19 LAMEA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 LAMEA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 LAMEA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 LAMEA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 LAMEA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 LAMEA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 LAMEA ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 LAMEA ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 LAMEA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 LAMEA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 30 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 31 LAMEA POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 LAMEA POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 LAMEA LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 LAMEA LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 BRAZIL CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 38 BRAZIL CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 39 BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 42 BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 43 BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 44 BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 45 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 46 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 47 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 52 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 53 UAE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 54 UAE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 55 UAE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 UAE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 UAE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 58 UAE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 59 UAE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 60 UAE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 61 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 62 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 63 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 66 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 67 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 68 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 69 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 70 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 71 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 72 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 73 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 74 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 75 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 76 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 77 NIGERIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 78 NIGERIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 79 NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 80 NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 81 NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 82 NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 83 NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 84 NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 85 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 86 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 87 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 88 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 89 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 90 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 91 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 92 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 93 KEY INFORMATION – TRIVITRON HEALTHCARE PVT. LTD.
TABLE 94 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 95 KEY INFORMATION – SIEMENS AG
TABLE 96 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 97 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 98 KEY INFORMATION – RANDOX LABORATORIES LIMITED
TABLE 99 KEY INFORMATION – DANAHER CORPORATION
TABLE 100 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 101 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 102 KEY INFORMATION – QUIDEL CORPORATION

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 SWOT ANALYSIS: ABBOTT LABORATORIES
FIG 4 SWOT ANALYSIS: SIEMENS AG
FIG 5 SWOT ANALYSIS: BECTON, DICKINSON AND COMPANY
FIG 6 SWOT ANALYSIS: DANAHER CORPORATION
FIG 7 SWOT ANALYSIS: THERMO FISHER SCIENTIFIC, INC.
FIG 8 SWOT ANALYSIS: JOHNSON & JOHNSON


More Publications